| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 532 | 725 | 734 | 797 | 578 | 580 | 649 | 565 | 390 | 427 | 378 | 351 | 390 | 370 | 444 | 477 | 403 | 399 | 357 | 406 | 395 | 409 | 453 | 441 | 359 | 12 | 8 | 429 | 6 | 0 | 89 |
| Expenses | 471 | 660 | 667 | 721 | 513 | 531 | 592 | 511 | 373 | 397 | 345 | 345 | 350 | 337 | 396 | 427 | 361 | 396 | 343 | 371 | 359 | 371 | 410 | 393 | 320 | 6 | 0 | 585 | 69 | 177 | 55 |
| EBITDA | 62 | 66 | 67 | 76 | 64 | 49 | 57 | 54 | 17 | 31 | 33 | 6 | 41 | 33 | 47 | 50 | 42 | 3 | 15 | 35 | 36 | 38 | 43 | 49 | 40 | 6 | 8 | -156 | -63 | -176 | 34 |
| Operating Profit % | 11 % | 9 % | 9 % | 9 % | 11 % | 8 % | 9 % | 10 % | 4 % | 7 % | 9 % | 1 % | 9 % | 8 % | 11 % | 10 % | 10 % | -2 % | 0 % | 4 % | 9 % | 7 % | 9 % | 11 % | 11 % | -10 % | 0 % | -36 % | -1,212 % | 0 % | 0 % |
| Depreciation | 16 | 16 | 17 | 15 | 16 | 14 | 15 | 15 | 15 | 15 | 15 | 15 | 14 | 14 | 14 | 14 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 16 | 0 | 0 | 16 | 1 | 0 | 0 |
| Interest | 30 | 44 | 36 | 39 | 32 | 33 | 31 | 31 | 28 | 28 | 31 | 26 | 26 | 18 | 18 | 17 | 21 | 21 | 18 | 20 | 18 | 21 | 25 | 24 | 20 | 0 | 0 | 18 | 0 | 0 | 30 |
| Profit Before Tax | 15 | 7 | 14 | 23 | 16 | 3 | 10 | 8 | -26 | -11 | -12 | -36 | 1 | 0 | 15 | 18 | 6 | -33 | -18 | 2 | 3 | 2 | 3 | 11 | 5 | 6 | 8 | -188 | -64 | -176 | 3 |
| Tax | 2 | 1 | 3 | 5 | 3 | 0 | 2 | 1 | -9 | -4 | -4 | 5 | -1 | -2 | 6 | 6 | 2 | -10 | -8 | -2 | 1 | 1 | 1 | 11 | 2 | -0 | 0 | -58 | -0 | 0 | -11 |
| Net Profit | 13 | 6 | 11 | 18 | 14 | 3 | 8 | 7 | -17 | -7 | -8 | -41 | 2 | 2 | 10 | 12 | 4 | -23 | -9 | 4 | 2 | 1 | 2 | 1 | 3 | 6 | 8 | -130 | -63 | -176 | 14 |
| EPS in ₹ | 0.59 | 0.26 | 0.49 | 0.78 | 0.61 | 0.11 | 0.37 | 0.33 | -0.75 | -0.33 | -0.36 | -1.83 | 0.08 | 0.08 | 0.43 | 0.52 | 0.17 | -1.00 | -0.41 | 0.16 | 0.08 | 0.05 | 0.07 | 0.03 | 0.13 | 0.25 | 0.35 | -5.80 | -2.82 | -7.85 | 0.64 |
Nectar Lifesciences
Nectar Lifesciences
13.40
-0.06
(-0.45%)
Market Cap
300.51 Cr
PE Ratio
-0.73
Volume
1,59,978.00
Day High - Low
13.78 - 13.20
52W High-Low
33.22 - 13.05
Key Fundamentals
Market Cap
300.51 Cr
EPS
-5.07
PE Ratio
-0.73
PB Ratio
0.36
Book Value
36.75
EBITDA
-24.60
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
-11.89
Debt to Equity
0.60
Actual
Company News
View All News
Nectar Lifesciences promoters' shareholding increased from 44.91% to 51.84% following completion of share buyback program that concluded on January 06, 2026.
Nectar Lifesciences, Nuvama Wealth, ideaForge Technology, Suryoday Small Finance Bank, and Coforge published their quarterly financial results for Q3FY26 ended December 31, 2025.
Nectar Lifesciences board approves new MOA to expand into construction and real estate, appoints VDR & Associates as internal auditor for FY26-27, and seeks shareholder approval via postal ballot.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,697.50 | #1 4,07,287.11 | 37.56 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 52.49 | |
6,168.50 | 1,63,754.29 | 66.27 | 9,712.00 | 18.67 | 2,191 | -1.02 | 48.87 | |
4,078.00 | 1,38,018.05 | 64.55 | 11,539.40 | 6.99 | 1,911 | 30.46 | 59.36 | |
1,331.50 | 1,07,554.81 | 23.69 | 28,409.50 | 7.12 | 5,291 | -57.18 | 35.86 | |
1,268.10 | 1,05,839.48 | 19.26 | 33,741.20 | 16.73 | 5,725 | -15.28 | 58.24 | |
2,199.30 | 1,00,463.76 | 23.23 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 56.93 | |
904.70 | 91,033.99 | #1 18.43 | 23,511.00 | 18.55 | 4,615 | -0.32 | 51.32 | |
2,060.50 | 85,058.49 | 47.59 | 12,744.20 | #1 20.90 | 2,007 | 7.65 | 42.02 | |
1,145.60 | 66,536.63 | 19.29 | 32,345.60 | 9.43 | 3,484 | 7.59 | 45.13 | |
5,402.50 | 64,594.99 | 29.06 | 13,458.30 | 3.70 | 2,216 | 10.98 | 36.02 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-1.40 %
Net Income Growth
-2,374.00 %
Cash Flow Change
-24.59 %
ROE
-2,629.79 %
ROCE
-198.03 %
EBITDA Margin (Avg.)
-115.03 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 2,511 | 2,556 | 2,581 | 2,724 | 2,705 | 2,633 | 2,471 | 2,391 | 2,189 | 2,191 | 2,047 |
| Fixed Assets | 934 | 906 | 881 | 852 | 825 | 785 | 772 | 723 | 662 | 643 | 633 |
| Current Assets | 1,369 | 1,464 | 1,496 | 1,661 | 1,669 | 1,615 | 1,239 | 1,355 | 1,231 | 1,284 | 1,238 |
| Capital Work in Progress | 91 | 99 | 102 | 100 | 100 | 115 | 99 | 85 | 78 | 66 | 57 |
| Investments | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 1,485 | 1,551 | 1,597 | 1,771 | 1,780 | 1,733 | 1,600 | 1,582 | 1,449 | 1,482 | 1,357 |
| Total Liabilities | 2,511 | 2,556 | 2,581 | 2,724 | 2,705 | 2,633 | 2,471 | 2,391 | 2,189 | 2,191 | 2,047 |
| Current Liabilities | 1,156 | 1,240 | 1,279 | 1,309 | 1,300 | 1,248 | 1,187 | 1,004 | 891 | 973 | 1,022 |
| Non Current Liabilities | 397 | 362 | 296 | 356 | 300 | 249 | 222 | 299 | 234 | 149 | 70 |
| Total Equity | 958 | 954 | 1,007 | 1,059 | 1,105 | 1,136 | 1,062 | 1,088 | 1,065 | 1,069 | 956 |
| Reserve & Surplus | 936 | 932 | 984 | 1,036 | 1,083 | 1,114 | 1,040 | 1,066 | 1,042 | 1,047 | 934 |
| Share Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 23 | 3 | -24 | -4 | 12 | 0 | 4 | -8 | -0 | 2 | -1 |
| Investing Activities | -60 | -77 | -18 | -29 | -26 | -33 | -29 | 17 | 52 | -17 | -42 |
| Operating Activities | 144 | 169 | 199 | 65 | 239 | 285 | 21 | 95 | 134 | 225 | 169 |
| Financing Activities | -62 | -89 | -204 | -40 | -201 | -252 | 12 | -119 | -186 | -205 | -128 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Jan 2026 |
| Promoter | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 55.80 % | 44.53 % | 44.53 % | 44.53 % | 44.91 % | 44.91 % | 51.84 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 14.59 % | 14.59 % | 14.59 % | 14.59 % | 14.59 % | 14.59 % | 16.97 % | 16.61 % | 3.24 % | 0.73 % | 1.65 % | 0.81 % | 0.62 % | 0.52 % | 0.58 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.16 % | 0.19 % | 0.09 % | 5.82 % | 3.54 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % |
| Public / Retail | 22.43 % | 21.99 % | 22.53 % | 23.60 % | 23.82 % | 24.20 % | 24.33 % | 24.52 % | 24.46 % | 24.61 % | 24.45 % | 24.34 % | 23.32 % | 23.69 % | 30.45 % | 39.36 % | 41.60 % | 44.12 % | 44.70 % | 39.72 % | 35.83 % |
| Others | 21.77 % | 22.21 % | 21.67 % | 20.60 % | 20.38 % | 20.00 % | 5.26 % | 5.07 % | 5.13 % | 4.98 % | 5.14 % | 5.25 % | 3.88 % | 3.87 % | 10.49 % | 15.35 % | 12.04 % | 10.32 % | 9.67 % | 9.00 % | 8.18 % |
| No of Share Holders | 0 | 47,394 | 53,304 | 55,124 | 56,073 | 64,012 | 63,909 | 62,940 | 64,422 | 61,582 | 60,283 | 60,761 | 59,946 | 58,230 | 66,741 | 69,482 | 69,241 | 71,977 | 76,470 | 78,124 | 76,648 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 21 Sept 2024 |  Annual General Meeting | NA | 21 Sept 2024 | 29.93 | 42.23 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 38.98 | 34.57 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 39.31 | 32.23 |
| 07 Jul 2025 | Quarterly Result Announcement | NA | 07 Jul 2025 | 25.05 | 22.76 |
| 04 Aug 2025 |  Extraordinary General Meeting | NA | 04 Aug 2025 | 22.76 | 16.25 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 14.02 | 15.23 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 15.24 | 14.42 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 14.65 | 15.92 |
| 31 Dec 2026 |  Buyback | 27 | 24 Dec 2025 | 19.09 | 18.58 |
| 23 Jan 2026 | Quarterly Result Announcement | NA | 23 Jan 2026 | 15.25 | 14.58 |
Announcements
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011
Jan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 29, 2026
Jan 29, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 28, 2026
Jan 28, 2026Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Jan 27, 2026
Jan 27, 2026Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Jan 27, 2026
Jan 27, 2026Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Jan 27, 2026
Jan 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 24, 2026
Jan 24, 2026Board Meeting Outcome for Outcome Of Board MeetingJan 23, 2026
Jan 23, 2026Results For Quarter And Nine Month Ended December 31 2025.Jan 23, 2026
Jan 23, 2026Extinguishment Of Equity Shares BoughtbackJan 21, 2026
Jan 21, 2026Board Meeting Intimation for Financial Results And Other Business MattersJan 19, 2026
Jan 19, 2026Post Buyback Public AnnouncementJan 16, 2026
Jan 16, 2026Announcement under Regulation 30 (LODR)-Post Buyback Public AnnouncementJan 15, 2026
Jan 15, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 03, 2026
Jan 03, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 30, 2025
Dec 30, 2025Letter Of Offer For BuybackDec 29, 2025
Dec 29, 2025Closure of Trading WindowDec 27, 2025
Dec 27, 2025Transfer Of The Business On A Slump Sale BasisDec 20, 2025
Dec 20, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Dec 15, 2025
Dec 15, 2025Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of SharesDec 10, 2025
Dec 10, 2025Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of SharesDec 05, 2025
Dec 05, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 03, 2025
Dec 03, 2025Fixed Record Date For BuybackDec 03, 2025
Dec 03, 2025Board Meeting Outcome for Meeting Held On December 03 2025Dec 03, 2025
Dec 03, 2025Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Nov 28, 2025
Nov 28, 2025Closure of Trading WindowNov 27, 2025
Nov 27, 2025Board Meeting Intimation for Proposal For Buyback Of Equity Shares Of The CompanyNov 27, 2025
Nov 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Nov 15, 2025Board Meeting Outcome for Outcome Of Board MeetingNov 14, 2025
Nov 14, 2025Results For Quarter And Half Year Ended September 30 2025.Nov 14, 2025
Nov 14, 2025Update On Slump SaleNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Change in ManagementNov 11, 2025
Nov 11, 2025Update On Slump SaleNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Change in ManagementNov 09, 2025
Nov 09, 2025Board Meeting Intimation for Financial Results And Other Business MattersNov 09, 2025
Nov 09, 2025Announcement under Regulation 30 (LODR)-Change in ManagementNov 04, 2025
Nov 04, 2025Disclosure Received In Terms Of Regulation 7(3) Of SEBI(Prohibition Of Insider Trading) Regulation 2015 (PIT Regulations).Nov 03, 2025
Nov 03, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 03, 2025
Nov 03, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Oct 31, 2025
Oct 31, 2025Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations)Oct 30, 2025
Oct 30, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateOct 27, 2025
Oct 27, 2025Satisfaction Of Charge On Full Repayment Of Secured Debt Along With The Accrued Interest To Consortium LendersOct 22, 2025
Oct 22, 2025Update On Slump SaleOct 17, 2025
Oct 17, 2025Minutes Of 30Th Annual General Meeting ("AGM")Oct 09, 2025
Oct 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 03, 2025
Oct 03, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 29, 2025
Sep 29, 2025Proceedings Of 30Th Annual General Meeting ("AGM").Sep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Update On Sale Of AssetsSep 16, 2025
Sep 16, 2025Update On Slump SaleSep 16, 2025
Sep 16, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.01% | 0 | 0.00% | -0.01% |
Technical Indicators
RSI(14)
Neutral 32.47
ATR(14)
Less Volatile 0.59
STOCH(9,6)
Neutral 34.38
STOCH RSI(14)
Neutral 78.11
MACD(12,26)
Bullish 0.15
ADX(14)
Strong Trend 31.03
UO(9)
Bearish 37.67
ROC(12)
Downtrend And Accelerating -2.33
WillR(14)
Neutral -75.81
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
